荷丹调脂方对小鼠脂质代谢的影响

蔡琳玲; 方丽文; 刘子修

荷丹调脂方对小鼠脂质代谢的影响

1.
东南大学附属中大医院，江苏南京 210009
2.
中国人民解放军东部战区空军医院药学部，江苏南京 210002

计量
- 文章访问数: 503
- HTML全文浏览量: 4
- PDF下载量: 342
- 被引次数: 0
出版历程
- 刊出日期: 2020-05-10

Effect of Hedan Tiaozhi Recipe on Lipid Metabolites in Mice

1.
Zhongda Hospital Affiliated to Southeast University, Nanjing, 210009, China
2.
Department of Pharmacy, Air Force Hospital of the Eastern Theater of the People’s Liberation Army of China, Nanjing, 210002, China

摘要

摘要: 目的研究荷丹调脂方对高脂血症小鼠血浆脂质代谢异常的调节作用。方法通过高效液相-二维线性离子阱高分辨静电场组合质谱仪(UPLC-LTQ/Orbitrap XL)的脂质组学研究方法，考察药物干预对脂质代谢的影响，寻找潜在生物标志物，探讨荷丹调脂方调节脂代谢的作用途径。结果正常组、模型组、荷丹调脂方组血浆脂质谱明显分离。鉴定了血浆中与荷丹调脂方影响的11种生物标志物，主要包括磷脂酰胆碱（PC）、溶血磷脂酰胆碱（LysoPC）和甘油三酯（TG）。荷丹调脂方干预对部分异常脂质代谢具有明显的改善作用。结论荷丹调脂方能有效缓解高脂饮食诱导的磷脂酰胆碱、溶血磷脂酰胆碱和甘油三酯代谢紊乱，表明荷丹调脂方调血脂的作用机制可能与调节这些代谢途径有关。
- 荷丹调脂方 /
- 液质联用 /
- 磷脂酰胆碱 /
- 溶血磷脂酰胆碱 /
- 甘油三酯
Abstract: OBJECTIVE To study the regulatory effect of Hedan Tiaozhi Recipe on abnormal plasma lipid metabolism in hyperlipidemia mice. METHODS By using UPLC-LTQ/Orbitrap XL， the effect of drug intervention on lipid metabolizer group was investigated， potential biomarkers were searched， and the action way of Hedan Tiaozhi Recipe in regulating lipid metabolism was explored. RESULTS Mass spectrometry of plasma lipids of normal group， model group and Hedan Tiaozhi Recipe group were all significantly separated. 11 biomarkers were identified in the plasma， mainly including phosphatidylcholine， lysophosphatidylcholine and triglycerideincluding phosphatidylcholine. The intervention of Hedan Tiaozhi Recipe significantly improved some abnormal lipid metabolism. CONCLUSION Hedan Tiaozhi Recipe can effectively alleviate the metabolism disorder of phosphatidylcholine， lysophosphatidylcholine and triglyceride induced by high-fat diet， which indicated that the mechanism of Hedan capsule regulating blood lipid may be related to the regulation of these metabolic pathways.
- Hedan capsule /
- HPLC-MS /
- phosphatidylcholine /
- lysophosphatidylcholine /
- triglyceride

HTML全文

参考文献(10)

[1]	REINER E. Hypertriglyceridaemia and risk of coronary artery disease [J].Nat Rev Cardiol， 2017，14: 401-411.
[2]	杨永革，王占庆，姜楠，等.他汀类药物的不良反应[J].医药导报，2011，30(6):817-820.
[3]	吴娜琼，徐瑞霞，李莎，等.荷丹片对高脂血症患者血脂谱、PCSK9水平及高密度脂蛋白颗粒的影响[J].中国动脉硬化杂志，2015，23(12):1277-1280.
[4]	张淑丽，王怡萍，杜振霞，等.基于UPLC-/TOF-MS技术的果糖诱导高尿酸血症大鼠血清脂质代谢组学研究[J].中国中药杂志，2016，41(6):1135-1139.
[5]	杜丽娜，单进军，谢彤，等.基于液相质谱联用的黄芩水提液抗病毒效应的脂质组学研究[J].中华中医药杂志，2015，30(5):1728-1733.
[6]	成玉，刘玉敏，黄凤杰，等.基于超高效液相色谱-四极杆飞行时间高分辨质谱的高通量血清代谢组学方法[J].高等学校化学学报，2013，34(1):77-83.
[7]	曹栋，裘爱泳，王兴国.磷脂及磷脂酰胆碱生物学功能[J]. 粮食与油脂， 2002，(11):23-24.
[8]	POLONCOVA K， GRIAC P. Phospholipid transport and remodeling in health and disease [J]. Gen Physiol Biophys， 2011， 30(5):25-35.
[9]	中国胆固醇教育计划委员会. 高甘油三酯血症及其心血管风险管理专家共识[J].中华心血管病杂志， 2017， 45(2):108.
[10]	XU R， WU N， SHA L， et al. Effects of Hedan Tablet on lipid profile， proprotein convertase subtilisin/kexin type 9 and high-density lipoprotein subfractions in patients with hyperlipidemia: A primary study [J]. Chin J Integr Med， 2016， 22(9):1-6.